Former FDA Regulator Warns of Politicized Drug Reviews at JPMorgan Forum
TL;DR Summary
Former FDA oncology chief Richard Pazdur, who left last month, told STAT at the JPMorgan Healthcare Conference that politicization is eroding the FDA’s firewall between political appointees and drug reviewers and that there’s insufficient transparency around a new expedited-review voucher program.
- Watch: At JPM, former drug regulator Richard Pazdur rings the alarm about politics at FDA statnews.com
- Pazdur warns that politics, ‘chaos’ are damaging FDA statnews.com
- Modernizing Accelerated Approval: One Of Pazdur’s Biggest Legacies Citeline News & Insights
- Former FDA Official Richard Pazdur Cites Political Interference and Internal Chaos as Challenges for Agency geneonline.com
- Pazdur Tells of FDA Turmoil; Surgeon's Data Questioned; MAHA's Supplement Boom MedPage Today
Reading Insights
Total Reads
0
Unique Readers
18
Time Saved
1 min
vs 2 min read
Condensed
86%
300 → 41 words
Want the full story? Read the original article
Read on statnews.com